Healthy Clinical Trial
Official title:
PAthway To Health (PATH): Fostering Culturally Appropriate Physical Activities Using Digital Technology in Indigenous Communities
Being physically active is important for everyone's health, but it is often challenging for people to start and sustain an activity routine. The investigators will develop and pilot test the PATH (PAthway To Health) program with Indigenous communities served by the Kwakiutl District Council (KDC) Health on North Vancouver Island. The project idea was conceived through a partnership between the communities and University of British Columbia health researchers. The PATH program will include an education sessions on how to be active, physical activity coaching by community health workers, and the use of Fitbit Flex (a wearable activity tracker). The investigators will develop a culturally appropriate online application to pair with Fitbit, which will provide instant feedback to individuals about their activity level. 60 community members will be recruited to test the PATH program. Their physical activity level, health status and use of activity resources at KDC Health Centres will be assessed.
Background: Promoting an active lifestyle is a priority identified by the communities served
by KDC Health. Statistics Canada estimates obesity in one in four adults based on 2007-2009
data, with higher prevalence among Indigenous people compared to non-Aboriginal population
(between 26% and 36% among adults living off-reserve and on-reserve, respectively).
Furthermore, Indigenous people also report higher prevalence of obesity associated
complications, including diabetes, cardiovascular disease, and arthritis. The association
between physical inactivity and obesity suggests that increasing physical activity is
important.
KDC Health offers a variety of free programs to community members, however, the use of these
services has been low. KDC Health has previously partnered with the CIHR-funded IMPAKT
project, and has expressed a strong interest in developing an intervention to improve health
and wellness in the communities.
Objectives:
1. To determine whether the PATH program can improve physical activity participation in
the communities served by KDC Health.
2. To assess the effect of this program on reducing sedentary time, and increasing the use
of health promotion and wellness services offered by KDC Health
3. To assess the correlation of physical activity levels and the secondary outcome
measures among individuals who are living in the same household.
Methods: The investigators will conduct a community-based proof-of-concept randomized
controlled trial (RCT) with 60 eligible participants. Only 1 member per household will be
enrolled. If more than 1 member is interested, they will select 1 person by consensus or by
a random draw.
After obtaining the baseline measures, participants will be randomly assigned to the 'Now
Group' (target=30) or 'Later Group' (target=30).
The Now Group will participate in a brief education session held at the KDC Health Centre,
use a wearable physical activity tracker (Fitbit Flex), and physical activity mentoring by a
KDC Health Staff (the Activity Mentors). The Activity Mentors have received training for the
project from the Principal Investigator. In Month 1-2, participants will meet with their
Activity Mentor once every 2 weeks to review their physical activity status, activity goals,
and the health programs available at the Centre. In Month 3-4, they will continue to use
Fitbit Flex but will no longer have regular meetings with the Activity Mentor.
The Later Group will receive intervention two months later (i.e., Month 3-4).
The primary outcome measure will be the time spent in moderate/vigorous physical activity.
In addition, time spent in sedentary behaviours will be recorded. Participants will wear a
SenseWear Mini accelerometer for 7 days at baseline, 2 months, and 4 months. Secondary
outcome measures include sedentary time measured with SenseWear Mini, health status that
will be measured using the SF-36 (a generic measure of health-related quality of life), and
body weight. Participants' use of KDC Health programs and their motivation to be physically
active will also be recorded.
At the end of the program, participants will be interviewed for 30 minutes in person about
their opinion on the intervention. Interviews will focus on 1) barriers/facilitators to
being physically active, 2) their experience with the intervention, and 3) the nature of
activities they engage in.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |